1747P Impact of prior chemotherapy (Chemo) on pembrolizumab (Pembro) response in urothelial cancer (UC): Exploratory analysis of the phase III KEYNOTE-045 study
| Autor: | De Wit, R., Vaughn, D.J., Fradet, Y., Fong, L., Vogelzang, N.J., Climent Duran, M.A., Necchi, A., Petrylak, D.P., Gerritsen, W.R., Gurney, H.P., Quinn, D.I., Culine, S., Sternberg, C.N., Bajorin, D.F., Choueiri, T.K., Xu, J., Imai, K., Homet Moreno, B., Bellmunt, J., Lee, J-L. |
|---|---|
| Zdroj: | In Annals of Oncology September 2022 33 Supplement 7:S1336-S1337 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|